Page 164 - 20211214_OHKF_Health_Finance_Research_Report_E (1)

4.3 THE FINANCIAL IMPACT OF A SCHEME
TO PROMOTE DIABETES MELLITUS

SCREENING AND MANAGEMENT

Beyond gaining perspectives from key stakeholders and the public, it is critical to further
explore the financial feasibility of implementing the Chronic Disease Screening
Voucher and Management Scheme (CDSVMS, also addressed as the “Scheme”) to
be designed. With a view towards understanding potential costs and using only diabetes
mellitus as a proxy for the implementation of the Scheme, we conducted an economic
analysis of possible forms of the Scheme over a 30-year time horizon with the target
audience–individuals between the age of 45–54 at the beginning of the projected time
horizon. We present findings from a Budget Impact Analysis (BIA) that would provide health
system planners and policymakers with a clearer view of the investment needed in
implementing this large-scale screening programme and would additionally showcase the
cost-benefits to the health system and budget if implemented.

4.3.1 DIABETES DISEASE PROFILE AND LITERATURE
REVIEW

Diabetes mellitus (DM) is a serious chronic condition that occurs either when the pancreas is
unable to produce enough insulin (a hormone that regulates blood sugar or glucose),
categorised as Type 1 diabetes, or when the body is unable to effectively use the insulin
it produces, categorised as Type 2 diabetes. DM has become an important area of
global discourse due to its rising prevalence, associated health complications, and
economic impact.

162